IP Library Patent Application 14531110
Patent Application
App. No. 14/531,110

Renovation and Repopulation of Decellularized Tissues and Cadaveric Organs by Stem Cells

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/531,110
Abstract

A method of manufacturing a tissue matrix for implantation into a patient is disclosed. The method sets forth collecting embryonic stem cells from a placenta which has been treated to remove residual cord blood and seeding the collected stem cells onto or into a tissue matrix. The seeded tissue matrix is then implanted on or into a patient. The seeded tissue matrix made by the method of the present invention is also disclosed.

Claims (14)

1 .- 23 . (canceled)

24 . A tissue comprising a decellularized organ and a plurality of non-placental cells.

25 . The tissue of claim 24 , wherein said decellularized organ is a placenta.

26 . The tissue of claim 24 , wherein said decellularized organ is a heart.

27 . The tissue of claim 24 , wherein the non-placental cells are stem cells or progenitor cells.

28 . The tissue of claim 27 , wherein the progenitor cells are progenitor cells for neurons, muscle, blood, bone, bone marrow, skin, heart, connective tissue, lung, kidney, liver, or pancreas.

29 . The tissue of claim 28 , wherein said progenitor cells for pancreas are progenitor cells for pancreatic islet cells.

30 . The tissue of claim 27 , wherein the stem cells are mesenchymal stem cells.

31 . The tissue of claim 30 , wherein said mesenchymal stem cells are from bone marrow.

32 . The tissue of claim 30 , wherein said mesenchymal stem cells are from embryonic yolk sac, umbilical cord, fetal skin, adolescent skin, or blood.

33 . The tissue of claim 24 , wherein the non-placental cells are on or more of hematopoietic cells, neuron cells, fibroblast cells, strand cells, or hepatic cells.

34 . The tissue of claim 24 , wherein the non-placental cells are stromal cells, endothelial cells, hepatocytes, or keratinocytes.

35 . The tissue of claim 24 , wherein the non-placental cells are cells that have been differentiated from placental stem cells.

36 . The tissue of claim 35 , wherein the cells that have been differentiated from placental stem cells are adipogenic cells, chondrogenic cells, osteogenic cells, myogenic cells, vasogenic cells, neurogenic cells, or hepatogenic cells.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2017
From: CLARITY ACQUISITION II LLC
To: CELULARITY, INC.
Reel/Frame 044780/0261 →
MERGER Recorded Nov 8, 2017
From: ANTHROGENESIS CORPORATION
To: CLARITY ACQUISITION II LLC
Reel/Frame 044413/0680 →